Publications by authors named "Christoph Pohl"

Claim this Profile
A
A Three-Phase Transport Model for High-Temperature Concrete Simulations Validated with X-ray CT Data.
Christoph Pohl, Vít Šmilauer, Jörg F Unger

Materials (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study.
Sabrina Mai Nielsen, Maarten Boers, Maarten de Wit, Beverly Shea, Danielle A van der Windt, Christoph Pohl

Semin Arthritis Rheum· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.
Matthias Englbrecht, Rieke Alten, Martin Aringer, Christoph G Baerwald, Harald Burkhardt, Christoph Pohl

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.
Kerstin Bendfeldt, Bernd Taschler, Laura Gaetano, Philip Madoerin, Pascal Kuster, Christoph Pohl

Brain Imaging Behav· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b.
Douglas S Goodin, Anthony T Reder, Anthony L Traboulsee, David Kb Li, Dawn Langdon, Christoph Pohl

Mult Scler· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
Dorothea Buck, Till Fm Andlauer, Wilmar Igl, Eva-Maria Wicklein, Mark Mühlau, Christoph Pohl

Mult Scler· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
Jennifer Petkovic, Jennifer L Barton, Caroline Flurey, Niti Goel, Christie M Bartels, Christoph Pohl

J Rheumatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
Monika E Finger, Annelies Boonen, Thasia G Woodworth, Reuben Escorpizo, Robin Christensen, Christoph Pohl

J Rheumatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The OMERACT First-time Participant Program: Fresh Eye from the New Guys.
Victor S Sloan, Shawna Grosskleg, Christoph Pohl, George A Wells, Jasvinder A Singh

J Rheumatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
Karine Toupin-April, Jennifer Barton, Liana Fraenkel, Linda C Li, Peter Brooks, Christoph Pohl

J Rheumatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.
Susan J Bartlett, Skye P Barbic, Vivian P Bykerk, Ernest H Choy, Rieke Alten, Christoph Pohl

J Rheumatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium intake and multiple sclerosis activity and progression in BENEFIT.
Kathryn C Fitzgerald, Kassandra L Munger, Hans-Peter Hartung, Mark S Freedman, Xavier Montalbán, Christoph Pohl

Ann Neurol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge.
Matthias Englbrecht, Rieke Alten, Martin Aringer, Christoph G Baerwald, Harald Burkhardt, Christoph Pohl

Arthritis Care Res (Hoboken)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.
Ludwig Kappos, Gilles Edan, Mark S Freedman, Xavier Montalbán, Hans-Peter Hartung, Christoph Pohl

Neurology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Sven Schippling, Paul O'Connor, Volker Knappertz, Christoph Pohl, Timon Bogumil

J Neurol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Clinically Important Difference as Applied in Rheumatology: An OMERACT Rasch Working Group Systematic Review and Critique.
Beyza Doganay Erdogan, Ying Ying Leung, Christoph Pohl, Alan Tennant, Philip G Conaghan

J Rheumatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.
Karine Toupin-April, Jennifer Barton, Liana Fraenkel, Linda Li, Viviane Grandpierre, Christoph Pohl

J Rheumatol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures.
Jennifer Petkovic, Jonathan Epstein, Rachelle Buchbinder, Vivian Welch, Tamara Rader, Christoph Pohl

J Rheumatol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Kathryn C Fitzgerald, Kassandra L Munger, Karl Köchert, Barry G W Arnason, Giancarlo Comi, Christoph Pohl

JAMA Neurol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.
Susan J Bartlett, Vivian P Bykerk, Roxanne Cooksey, Ernest H Choy, Rieke Alten, Christoph Pohl

J Rheumatol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b.
Hans-Peter Hartung, Ludwig Kappos, Douglas S Goodin, Paul O'Connor, Massimo Filippi, Christoph Pohl

J Neurol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Kassandra L Munger, Kathryn C Fitzgerald, Mark S Freedman, Hans-Peter Hartung, David H Miller, Christoph Pohl

Neurology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The OMERACT First-time Participant ("Newbie") Program: Initial Assessment and Lessons Learned.
Victor S Sloan, Shawna Grosskleg, Christoph Pohl, George A Wells, Jasvinder A Singh

J Rheumatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program.
Kathrine Lederballe Grøn, Lykke Midtbøll Ornbjerg, Merete Lund Hetland, Fawad Aslam, Nasim A Khan, Christoph Pohl

Clin Exp Rheumatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanism underlying the impact of vitamin D on disease activity of MS.
Kassandra L Munger, Karl Köchert, Kelly C Simon, Ludwig Kappos, Chris H Polman, Christoph Pohl

Ann Clin Transl Neurol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis